Frontiers in oncology.

A multidisciplinary team (MDT) in oncology is defined as the cooperation between different specialized professionals involved in cancer care with the overarching goal of improving treatment efficiency and patient care. Head and neck cancer (HNC) involves multiple and biologically distinct diseases that require different therapeutic approaches.Frontiers articles are indexed in a number of major international digital archives and repositories, such as PubMed Central, DOAJ, Google Scholar, Chemical Abstracts Service. For additional details on specific indexing, please see the individual journals’ About page.Getting started. The submitting and corresponding author (s) must register and log in with Frontiers to be able to follow the review process. Ensure that your manuscript fits the scope of the journal/section/Research Topic in which it will be submitted and that you have chosen the correct article type. Submission of the wrong article type or to ...Terms and conditions. Part of a multidisciplinary journal, this section explores new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence.Master protocols in oncology allow detection of specific signal pathways strongly associated with driver gene mutations, cancer cell growth, and progression . A basket trial is a particular type of master protocol that evaluates the efficacy and safety of a targeted therapy in multiple diseases that share a common molecular alteration ( 11 ) or …

liang qiao. Faculty of Medicine and Health, The University of Sydney. Sydney, Australia. Specialty Chief Editor. Gastrointestinal Cancers: Colorectal Cancer.liang qiao. Faculty of Medicine and Health, The University of Sydney. Sydney, Australia. Specialty Chief Editor. Gastrointestinal Cancers: Colorectal Cancer.Our vision for the program is Comprehensive Cancer Care and Optimized Cancer Survival by 2025. We hope to achieve the vision of our country, that is, the ...

Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ...

The BSc Medical Sciences with Cancer Frontiers programme is designed to provide an understanding of the scientific basis of cancer and how this relates to ...Resurchify provides impact factor, h-index, SJR, ranking, publisher, ISSN, and other details of Frontiers in Oncology, a cancer research journal. See …Another fast-growing research area in radiation oncology is radiomics which uses data-characterization algorithms to extract features from radiological images, detect patterns, and uncover cancer characteristics as images contain much more information than perceived by the imaging interpreter or the clinician.Frontiers in Oncology 影响因子：4.848 Frontiers in Oral Health. P. Frontiers in Pediatrics 影响因子：2.634 Frontiers in Pharmacology 影响因子：4.225

Milan Teraiya. Helene Perreault. Vincent C. Chen. Frontiers in Oncology. doi 10.3389/fonc.2023.1166207. 5,424 views. 2 citations. Explores intracellular and extracellular signaling across all types of cancers.

Frontiers in Oncology publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies.

See all (60) Learn more about Research Topics. Part of a multidisciplinary journal, this section explores the development of personalized and tailored approaches to the prevention, diagnosis, and treatment of breast malignancies.Apr 23, 2024 ... Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways. Rong Wang ...Please note, as Frontiers and Loop are fully integrated, you can use the same credentials for both websites. If you would like to merge these accounts, please contact our support office . Alternatively, you can continue , but we will not be able to validate the invitation.liang qiao. Faculty of Medicine and Health, The University of Sydney. Sydney, Australia. Specialty Chief Editor. Gastrointestinal Cancers: Colorectal Cancer.» Frontiers in Oncology. Abbreviation: FRONT ONCOL ISSN: 2234-943X eISSN: 2234-943X Category / Quartile: ONCOLOGY - SCIE(Q2) WoS Core Citation Indexes: SCIE - Science Citation Index Expanded. Impact Factor (IF): 4.7 Journal Citation Indicator (JCI): 0.89 Citations: 43,416Background. Immune checkpoint inhibitors (ICIs) are a class of antitumor drug that activate lymphocytes, which then attack tumor cells by relieving immune checkpoint-mediated immune-suppression (1, 2).In 2015, two types of ICIs (nivolumab and pembrolizumab) were approved by the U.S. Food and Drug Administration for the …

Master protocols in oncology allow detection of specific signal pathways strongly associated with driver gene mutations, cancer cell growth, and progression . A basket trial is a particular type of master protocol that evaluates the efficacy and safety of a targeted therapy in multiple diseases that share a common molecular alteration ( 11 ) or …Frontiers operates a single-blind model during the review process. This means the reviewers know who the authors are in order to offer a full assessment within the context of their research and to ensure they can avoid any potential competing interests in accepting a review invitation. Frontiers also believes that reviewers should be ...Yu Zhu. Jixiang Chu. Dan Luo. Hai-Long Dai. Chengde Liao. Frontiers in Oncology. doi 10.3389/fonc.2024.1394708. This section advances our understanding of thoracic malignancies, namely pleural tumors, thymic malignancies, lung and mediastinal tumors, lung carcinoids, chest wall tumors and tracheal tumors.Visitors may also download and forward articles subject to the citation requirements and subject to any fees POR's publisher, Frontiers, may charge for ...In 2019, in Italy, 53,000 new cases of breast cancer have been reported, representing the most commonly diagnosed cancer in women: it can be estimated that …

Tumor-initiating cells (TICs) share many functional characteristics with normal stem cells and are important drivers of tumor initiation and cancer progression (1–7). As such, new therapies for targeting TICs [a.k.a., cancer stem cells (CSCs)] could be used for cancer prevention.

Scope. This section of the journal will focus on the basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. This broadly includes mitochondrial, glycolytic, fatty acid, as well as other forms of metabolism.Mohamed Rahouma. Massimo Baudo. Magdy M. El-Sayed Ahmed. Frontiers in Oncology. doi 10.3389/fonc.2023.1271452. 776 views. Part of a forward-thinking journal, this section covers the entire emerging interface between cardiovascular medicine and oncology.In Vitro Peptide Re-Stimulation (IVS) of the Murine Splenocytes. Fresh splenocytes isolated from vaccinated animals were stimulated with either HAGE 30-mer long peptides, WT1 15-mer long peptides or both, at a concentration of 1μg/mL in the presence of β-mercaptoethanol and 50U/mL mIL-2 for 7 days at 37°C in a 5% (v/v) CO 2 incubator.A recent retrospective analysis on 152 advanced OSCC patients examined the outcome of cancer therapy and the incidence of tumor recurrence after PBM (660 nm, 40 mW, 10 J/cm 2) for the prevention of OM. Results showed that prophylactic PBM did not influence treatment outcome of primary cancer, recurrence, the development of new primary tumors ... Available at: https://persistent-url (Accessed March 15, 2018). This section explores basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. The Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers section aims at offering a wide and comprehensive approach to investigations concerning tumorigenesis, prevention, early detection and treatment of HPB neoplasia. Even though the molecular machinery triggering and sustaining HPB carcinogenesis and the morphogenetic …Jul 6, 2018 · The Impact Factor for Frontiers in Oncology is based on 2,358 citations in 2017 to 296 articles published in 2015 and 2016, and for CiteScore is based on 4,138 citations in 2017 to 930 articles published in 2014, 2015 and 2016. A total of 222 journals are listed in the Oncology category in the 2017 JCR edition, of which 37 are Open Access. Introduction. Non-communicable Diseases (NCD) were responsible for 15 million premature deaths (30-69 years) worldwide in 2016, with more than 85% of these deaths occurring in low- and middle …New Therapeutic Approaches for Pediatric Glioma: Pre-Clinical and Clinical Studies. Mark Atlas. Derek Hanson. Oren Becher. 395 views. This section aims to create an open access, rapid, transparent and interactive exchange of findings for the neuro-oncology and neurosurgical oncology communities.Optimizing the first-line treatment for metastatic colorectal cancer. The prognosis of metastatic CRC (mCRC) patients has significantly improved in the past 20 years thanks to the introduction of novel therapeutic approaches, including surgery of liver, lung and peritoneal metastases, and of more effective anticancer drugs and combinatory ...

Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ...

LetPub整理了最新的Frontiers in Oncology 期刊投稿经验， 期刊官方投稿网址，影响因子，审稿周期/时间，研究方向，SCI期刊分区，中国作者发表的文章等信息， ...

A recent retrospective analysis on 152 advanced OSCC patients examined the outcome of cancer therapy and the incidence of tumor recurrence after PBM (660 nm, 40 mW, 10 J/cm 2) for the prevention of OM. Results showed that prophylactic PBM did not influence treatment outcome of primary cancer, recurrence, the development of new primary tumors ...Perspective: rethinking therapeutic strategies in oncology. Immuno-oncology has revolutionized cancer care, drug development, the design of clinical trials, standard treatment paradigms, and the evaluation of response to therapy. These are all areas, however, that have not fully incorporated principles of tumor immunology.May 8, 2024 · Yutaka Tamura. Kengo Yoshii. Tomoharu Sugie. Mitsugu Sekimoto. Frontiers in Oncology. doi 10.3389/fonc.2024.1365305. 844 views. This section explores high-quality research concerning all aspects of cancer and benign neoplasm drug treatment. Frontiers in Oncology is an open access journal that covers all areas of cancer research, from epidemiology to therapeutics. It is led by Field Chief Editor Prof Giuseppe Giaccone and publishes original research, reviews, and perspectives in various specialty sections. Frontiers works with research institutions, libraries, consortia, and funders to support authors who want to publish in a Frontiers journal. A central invoicing platform removes the burden from authors and helps contribute to the growing number of research articles that are openly available to all. Organizations can become institutional members ...The Cancer Epidemiology and Prevention section aims to publish rigorous research which gives new insights into the distribution, etiology, prevention, survivorship, and surveillance of cancer incidence. Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and ...The official journal of the International Union of Immunological Societies (IUIS) and the most cited in its field, leading the way for research across basic, translational and clinical immunology.Frontiers | Registration - Frontiers | Peer Reviewed Articles1 Introduction. Colorectal cancer (CRC) is the third most common cancer worldwide (colon: 1,148,515; rectum: 732,210) and the second leading cause of cancer-related deaths (colon: 935,000; rectum: 339,022) in 2020.There were about 555,000 new cases of colorectal cancer in China in 2020, accounting for 12.2% of the number of new …This section provides broad mechanistic and translational insights into all aspects of cancer and its interaction with components of the tumor-microenvironment.

Artificial Intelligence (AI) has many possible applications in Oncology. One of the most promising is the potential for AI to represent and/or infer processes from real-world data. On one hand, the availability of the pattern of care is growing in opportunities (e.g. new markers, devices, drugs, etc.), constraints (guidelines, protocols, legal issues), and needs (e.g. investments, sustainable ...Telemedicine in Oncology: Delivering on an Overdue Promise in the COVID-19 Era. Telemedicine has historically been underutilized in medicine broadly, and specifically in oncology, despite the general availability of the needed infrastructure to offer it as a platform for remote care. The COVID-19 pandemic posed new risks of infection …Guohui Cao. Hongtao Zhang. Juan Wang. Frontiers in Oncology. doi 10.3389/fonc.2024.1339955. 304 views. Part of a multidisciplinary journal, this section explores the impact of genetic aberrations in carcinogenesis, as well as in the progression and outcomes of cancer.Special Issue Information. Dear Colleagues,. Pancreatic adenocarcinoma is an aggressive malignancy associated with poor prognosis and is the fourth most common ...Instagram:https://instagram. upside gasclickasnap appgood high protein breakfastdata analysis courses 3. Segmentation: To achieve reliable radiomic models in oncology, robustly and precisely delineating lesions is essential. However, traditional manual segmentation usually takes a very long time to perform, generates interobserver variability, and requires the involvement of experienced radiologists for analysis. j jb hfijeopardy show michael kattan. Cleveland Clinic Lerner College of Medicine, School of Medicine, Case Western Reserve University. Cleveland, United States. Specialty Chief Editor. Genitourinary Oncology. dallas texas to new orleans Our goal is to encourage interdisciplinary communication and collaborative research among basic scientists, epidemiologists, clinicians, and public health …Frontier Airlines is a popular low-cost carrier that offers budget-friendly travel options for those looking to explore new destinations without breaking the bank. With a focus on ...